BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//wp-events-plugin.com//7.2.3.1//EN
TZID:America/Phoenix
X-WR-TIMEZONE:America/Phoenix
BEGIN:VEVENT
UID:1794@azbio.org
DTSTART;TZID=America/Phoenix:20230314T120000
DTEND;TZID=America/Phoenix:20230314T130000
DTSTAMP:20230223T030714Z
URL:https://www.azbio.org/events/is-your-life-sciences-patent-enabled-u-s-
 supreme-court-will-decide-this-year
SUMMARY:Is Your Life Sciences Patent Enabled? U.S. Supreme Court Will Decid
 e This Year -  - 14 Mar 23 12:00
DESCRIPTION:\nIn this year’s foray into patent law\, the Supreme Court wi
 ll decide whether Amgen’s patent that claims antibodies by functional an
 tigen binding and does not disclose the full range of antibody sequences i
 s invalid for not meeting the enablement requirements of Section 112(b).\n
 Join us for this webinar on Tuesday\, March 14 where Procopio experts in p
 atent prosecution and patent litigation will discuss the background of the
  case and how the Supreme Court’s decision may impact the ability to obt
 ain certain life science\, chemical and pharma patents and how it may prov
 ide additional ammunition to attack such patents in patent litigation.\nMa
 rch 14 at 12:00-1:00pm (AZ Time and PT) via Zoom\nRegister here: https://
 zoom.us/meeting/register/tJwpd-2vqDguGtNGiNp3qn2p6dFCpt65kpEv
END:VEVENT
BEGIN:VTIMEZONE
TZID:America/Phoenix
X-LIC-LOCATION:America/Phoenix
BEGIN:STANDARD
DTSTART:20220314T120000
TZOFFSETFROM:-0700
TZOFFSETTO:-0700
TZNAME:MST
END:STANDARD
END:VTIMEZONE
END:VCALENDAR